Optimizing Abdominoplasty Surgical Site Morbidity Profiling Through an Effective and Nationally Validated Risk Scoring System.

Annals of plastic surgery 2022 Vol.88(3 Suppl 3) p. S274-S278

Massada KE, Baltodano PA, Webster TK, Elmer NA, Zhao H, Lu X, Kaplunov BS, Araya S, Brebion R, Coronado M, Patel SA

관련 도메인

Abstract

[BACKGROUND] Abdominoplasty complication rates are among the highest for cosmetic surgery. We sought to create a validated scoring system to predict the likelihood of wound complications after abdominoplasty using a national multi-institutional database.

[METHODS] Patients who underwent abdominoplasty in the American College of Surgeons National Surgical Quality Improvement Program 2007-2019 database were analyzed for surgical site complications, a composite outcome of wound disruption, and surgical site infections. The cohort was randomly divided into a 60% testing and a 40% validation sample. Multivariable logistic regression analysis was performed to identify independent predictors of complications using the testing sample (n = 11,294). The predictors were weighted according to β coefficients to develop an integer-based clinical risk score. This system was validated using receiver operating characteristic analysis of the validation sample (n = 7528).

[RESULTS] A total of 18,822 abdominoplasty procedures were identified. The proportion of patients who developed a composite surgical site complication was 6.8%. Independent risk factors for composite surgical site complication included inpatient procedure (P < 0.01), smoking (P < 0.01), American Society of Anesthesiologists class ≥3 (P < 0.01), and body mass index ≥25.0 and ≤18.0 kg/m2 (P < 0.01). African American race was a protective factor against surgical site complications (P < 0.01). The factors were integrated into a scoring system, ranging from -5 to 42, and the receiver operating characteristic analysis revealed an area under the curve of 0.71.

[CONCLUSIONS] We present a validated scoring system for postoperative 30-day surgical site morbidity after abdominoplasty. This system will enable surgeons to optimize patient selection to decrease morbidity and unnecessary healthcare expenditure.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 abdominoplasty 복부성형술 dict 6
합병증 wound scispacy 1
약물 [BACKGROUND] Abdominoplasty scispacy 1
약물 [RESULTS] A scispacy 1
질환 infections C0851162
Infections of musculoskeletal system
scispacy 1

MeSH Terms

Abdominoplasty; Cohort Studies; Humans; Morbidity; Postoperative Complications; Retrospective Studies; Risk Factors

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문